Project Grant R01DK145690
- Federal Project Grant Award Summary Scripps Health received a $574,932 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective July 1, 2026 through June 30, 2031. The award funds the EDGE (Enhancing Dulce Digital with CGM-Driven Personalization, Peer Support, Gamification, and Engagement) intervention, a digital health platform designed to improve...
- Federal Project Grant Award Summary Brigham & Women's Hospital Inc. received a $891,382 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 15, 2026, with completion scheduled for February 28, 2031. The award funds a multisite real-world evaluation of continuous glucose monitoring (CGM) systems in older adults with type 2 diabetes...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $799,752 on July 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support a five-year clinical research study comparing continuous glucose monitoring (CGM) technologies with traditional blood glucose self-monitoring in non-insulin-treated adults with poorly controlled Type 2 Diabetes Mellitus (T2DM). The Research...
- Summary of Federal Project Grant Award The University of Michigan received a $769,155 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), with an award date of September 12, 2025, and completion date of July 31, 2030. The grant funds the Michigan Diabetes Project, a research initiative designed to develop and evaluate a virtually administered,...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the Regents of the University of Michigan a $779,978 Project Grant on September 6, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This research initiative addresses critical health disparities in diabetes management by developing and testing adaptive intervention sequences designed to improve outcomes for individuals with...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $1.48 million Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the University of Colorado-Denver on September 5, 2025, with completion targeted for June 30, 2030. The project, titled "Extending Inferences of Efficacy and Selection of Transformative Diabetes Therapies to Diverse Populations," addresses critical...
- Federal Project Grant Award Summary Aurora Health Care, Inc. received a Project Grant award of $762,556 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, with completion targeted for June 30, 2030. The award funds development of a novel, semi-automated self-monitoring feedback system designed to enhance weight loss interventions in...
- Federal Project Grant Award Summary Rush University Medical Center received a $942,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on September 16, 2025, with a completion date of August 31, 2028. The award funds a feasibility research project designed to develop and evaluate a primary care-based weight management intervention program for patients...
- Federal Project Grant Award Summary Scripps Health received a $331,277 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded on September 15, 2025, with a completion date of July 31, 2030. The grant supports Dr. San Diego's research to integrate continuous glucose monitoring (CGM) technology into diabetes self-management education for Latino adults...
- Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases awarded a Project Grant of $784,276 to the University of Houston, effective July 1, 2026 through June 30, 2031, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research project, titled "Supporting Monitoring and Remote Tracking for Prediabetes (SMART Prediabetes)," develops and evaluates continuous glucose monitor (CGM) use in federally qualified...
HealthPartners Institute received a $314,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on July 15, 2026, with a completion date of May 31, 2029. The award funds the RISE-CGM (Real-Time Insights for Smart Engagement with Continuous Glucose Monitoring) initiative, a 28-week digital behavior change intervention designed to improve glycemic control and self-management outcomes in individuals with type 2 diabetes. The intervention combines evidence-based nutrition and lifestyle education with real-time continuous glucose monitoring (CGM) data and personalized text messaging to deliver just-in-time behavioral support grounded in self-determination theory. The RISE-CGM program delivers a scalable intervention consisting of a 16-week active phase followed by a 12-week maintenance period. The service employs real-time CGM data integration alongside systematic retrospective glucose data reviews to help participants understand how food and lifestyle choices impact blood glucose levels, with the objective of driving sustainable behavior changes and improved diabetes outcomes. HealthPartners Institute will conduct this research using the Obesity-Related Behavioral Intervention Trials (ORBIT) framework at its Bloomington, Minnesota location, leveraging the organization's existing clinical infrastructure and patient populations to advance evidence-based digital health solutions for diabetes management.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $314.0k | 7/16/26 |